CpG drives human transitional B cells to terminal differentiation and production of natural antibodies

Journal of Immunology

Volumn 180, Issue 2, 2008, Pages 800-808

  Capolunghi, Federica ^a   Cascioli, Simona ^a   Giorda, Ezio ^a   Rosado, Maria Manuela ^a   Plebani, Alessandro ^b   Auriti, Cinzia ^a   Seganti, Giulio ^a   Zuntini, Roberta ^c   Ferrari, Simona ^c   Cagliuso, Maria ^d   Quinti, Isabella ^d   Carsetti, Rita ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BACTERIAL DNA; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR 9; AICDA (ACTIVATION INDUCED CYTIDINE DEAMINASE); AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); BACTERIAL PROTEIN; CYTIDINE DEAMINASE; PHOSPHOTRANSFERASE; PNPS PROTEIN, STREPTOCOCCUS PNEUMONIAE; POLYSACCHARIDE; TLR9 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOSTIMULATION; INNATE IMMUNITY; MEMORY CELL; NEWBORN; NORMAL HUMAN; PHENOTYPIC VARIATION; PLASMA CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; STREPTOCOCCUS PNEUMONIAE; UMBILICAL CORD BLOOD; B LYMPHOCYTE; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; CPG ISLAND; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; SPLEEN;

ANTIBODY FORMATION; B-LYMPHOCYTE SUBSETS; BACTERIAL PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CPG ISLANDS; CYTIDINE DEAMINASE; DNA, BACTERIAL; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; PHOSPHOTRANSFERASES; PLASMA CELLS; POLYSACCHARIDES; SPLEEN; TOLL-LIKE RECEPTOR 9;

EID: 40449137383     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.2.800     Document Type: Article

References (53)

1. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
2. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintainance of serological memory by policlonal activation of human memory B cells. Science 298: 2199-2202.
3. Lemaitre, B., E. Nicolas, L. Michaut, J. M. Reichart, and J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spätzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983.
4. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
5. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135-145.
6. Akira, S., and S. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
7. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
8. Ku, C. L., K. Yang, J. Bustamante, A. Puel, H. von Bernuth, O. F. Santos, T. Lawrence, H. H. Chang, H. Al-Mousa, C. Picard, and J. L. Casanova. 2005. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol. Rev. 203: 10-20.
9. Cook, D. N., D. S. Pisetsky, and D. A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979.
10. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, S. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
11. Coban, C., K. J. Ishii, T. Kawai, H. Hemmi, S. Sato, S. Uematsu, M. Yamamoto, O. Takeuchi, S. Itagaki, N. Kumar, et al. 2005. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J. Exp. Med. 201: 19-25.
12. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537.
13. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
14. Klinman, D. M. 2004. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4: 249-258.
15. Huggins, J., T. Pellegrin, R. E. Felgar, C. Wie, M. Brown, B. Zheng, E. C. B. Milner, S. H. Bernstein, I. Sanz, and M. S. Zand. 2007. CpG DNA activation and plasma cell differentiation of CD27- naive human B cells. Blood 109: 1611-1619.
16. He, B., X. Qiao, and A. Cerutti. 2004. CpG DNA induces class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173: 4479-4491.
17. Ertesvag, A., H. C. Aasheim, S. Naderi, and H. K. Blomhof. 2007. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK. Blood 109: 3865-3872.
18. Poeck, H., M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2004. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103: 3058-3064.
19. Brummel, R., and P. Lenert. 2005. Activation of Marginal Zone B cells from Lupus mice with type A(D) CpG-oligodeoxynucleotides. J. Immunol. 174: 2429-2434.
20. Klein, U., R. Küppers, and K. Rajewsky. 1997. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood 89: 1288-1298.
21. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
22. Kruetzmann, S., M. M. Rosado, H. Weber, U. Germing, O. Tournilhac, H. H. Peter, R. Berner, T. Boehm, A. Plebani, I. Quinti, and R. Carsetti. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197: 939-945.
23. Carsetti, R., M. M. Rosado, and H. Wardmann. 2004. Peripheral development of B cells in mouse and man. Immunol. Rev. 197: 179-191.
24. Weller, S., A. Faili, C. Garcia, M. C. Braun, F. F. Le Deist, G. G. de Saint Basile, O. Hermine, A. Fischer, C. A. Reynaud, and J. C. Weill. 2001. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA 98: 1166-1170.
25. Weller, S., M. C. Braun, B. K. Tan, A. Rosenwald, C. Cordier, M. E. Conley, A. Plebani, D. S. Kumararatne, D. Bonnet, O. Tournilhac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
26. Carsetti, R., M. M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, A. Meini, A. Plebani, F. Aiuti, and I. Quinti. 2005. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol. 115: 412-417.
27. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
28. Avery, D. T., J. I. Ellyard, F. Mackay, L. M. Corcoran, P. D. Hodgkin, and S. G. Tangye. 2005. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J. Immunol. 174: 4034-4042.
29. Sims, G. P., R. Ettinger, Y. Shirota, C. H. Yarboro, G. G. Illei, and P. E. Lipsky. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
30. Cuss, A. K., D. T. Avery, J. L. Cannons, L. J. Yu, K. E. Nichols, P. J. Shaw, and S. G. Tangye. 2006. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J. Immunol. 176: 1506-1516.
31. Zhou, J., K. R. Lottenbach, S. J. Barenkamp, and D. C. Reason. 2004. Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 6B. Infect. Immun. 72: 3505-3514.
32. Weller, S., C. A. Reynaud, and J. C. Weill. 2005. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol. 26: 85-89.
33. Durandy, A. 2003. Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation. Eur. J. Immunol. 33: 2069-2073.
34. Shinkura, R., S. Ito, N. A. Begum, H. Nagaoka, M. Muramatsu, K. Kinoshita, Y. Sakakibara, H. Hijikata, and T. Honjo. 2004. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5: 707-712.
35. Shaffer, A. L., K. I. Lin, T. C. Kuo, X. Yu, M. E. Hurt, A. Rosenwald, J. M. Giltnane, L. Yang, H. Zhao, K. Calame, and L. M. Staudt. 2002. Blimp-1 orchestrate plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
36. Suzuki, T., P. J. Higgins, and D. R. Crawford. 2000. Control selection for RNA quantitation. BioTechniques 29: 332-337.
37. Schmittgen T. D., and B. A. Zakrajsek. 2000. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J. Biochem. Biophys. Methods 46: 69-81.
38. Bustin, S. A. 2000. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assay. J. Mol. Endocrinol. 25: 169-193.
39. Barbini, L., J. Rodríguez, F. Dominguez, and F. Vega. 2007. Glyceraldehyde-3-phosphate dehydrogenase exerts different biologic activities in apoptotic and proliferating hepatocytes according to its subcellular localization. Mol. Cell Biochem. 300: 19-28.
40. Macpherson, A. J., and N. L. Harris. 2004. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4: 478-485.
41. Conley, M. E., A. Broides, V. Hernandez-Trujillo, V. Howard, H. Kanegane, T. Miyawaki, and S. A. Shurtleff. 2005. Genetic analysis of patients with defects in early B-cell development. Immunol. Rev. 203: 216-234.
42. Imai, K., N. Catalan, A. Plebani, L. Maródi, O. Sanal, S. Kumaki, V. Nagendran, P. Wood, C. Glastre, F. Sarrot-Reynauld, et al. 2003. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J. Clin. Invest. 112: 136-142.
43. Durandy, A., P. Revy, K. Imai, and A. Fischer. 2005. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol. Rev. 203: 67-79.
44. Ueda, Y., D. Liao, K. Yang, A. Patel, and G. Kelsoe. 2007. T-independent activation-induced cytidine deaminase expression, class switch recombination, and antibody production by immature/transitional 1 B cells. J. Immunol. 178: 3593-3601.
45. Liu, N., N. Ohnishi, L. Ni, S. Akira, and K. B. Bacon. 2003. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells. Nat. Immunol. 4: 687-693.
46. Carsetti, R., G. Köhler, and M. C. Lamers. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181: 2129-2140.
47. King, L. B., and J. G. Monroe. 2000. Immunobiology of the immature B cell: plasticity in the B-cell antigen receptor-induced response fine tunes negative selection. Immunol. Rev. 176: 86-104.
48. Su, T. T., B. Guo, B. Wei, J. Braun, and D. J. Rawlings. 2004. Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol. Rev. 197: 161-178.
49. Pietzak, M. 2004. Bacterial colonization of neonatal gut. J. Pediatr. Gastroenterol. Nutr. 38: 389-391.
50. Hangartner, L., R. Zinkernagel, and H. Hengartner. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6: 231-243.
51. Schutze, G. E., E. O. Mason, W. J. Barson, K. S. Kim, E. R. Wald, L. B. Givner, T. Q. Tan, J. S. Bradley, R. Yogev, and S. L. Kaplan. 2002. Invasive pneumococcal infections in children with asplenia. Pediatr. Infect. Dis. J. 21: 278-282.
52. Steiniger, B., P. Barth, and A. Hellinger. 2001. The perifollicular and marginal zones of the human splenic white pulp: do fibroblasts guide lymphocyte immigration? Am. J. Pathol. 159: 501-512.
53. Brendolan, A., M. M. Rosado, R. Carsetti, L. Selleri, and T. N. Dear. 2007. Development and function of the mammalian spleen. Bioessays 29: 166-177.